CTST CLASS ACTION UPDATE: Hagens Berman Notifies CannTrust

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
46
CTST CLASS ACTION UPDATE: Hagens Berman Notifies CannTrust (CTST) Investors of July 11, 2019 News, Encourages Investors Who Suffered $50,000+ Losses to Contact the Firm

SAN FRANCISCO, July 12, 2019 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, with nine offices in eight cities around the country and eighty attorneys, reminds investors in CannTrust Holdings Inc. (NYSE: CTST) of the Lead Plaintiff deadline in the securities class action, Huang v. CannTrust Holdings Inc. et al., No. 1:19-cv-06396, filed in the U.S. District Court for the Southern District of New York and updates investors concerning recent news.

If you purchased or otherwise acquired CannTrust securities between November 14, 2018 and July 5, 2019 (the “Class Period”) and suffered losses you do not need to sign up to be included in the putative class of investors.

If you suffered significant losses (in excess of $50,000), you may qualify to be a lead plaintiff – one who selects and oversees the attorneys prosecuting the case.  If you wish to serve as a lead plaintiff in this class action, you must move the Court no later than September 9, 2019 (the “Lead Plaintiff deadline”) .  Contact Hagens Berman immediately for more information about the case and being a lead plaintiff:

https://www.hbsslaw.com/hagens-berman-fraud-center/canntrust

or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing

CTST@hbsslaw.com .

According to the complaint, Defendants misrepresented and concealed that CannTrust was growing cannabis in its Pelham, Ontario greenhouse facility in five unlicensed rooms between October and March 2018, and that the Company was providing inaccurate information to Canadian regulator (Health Canada).

On July 8, 2019, the market began to learn the truth when Defendants disclosed that Health Canada found that the Pelham greenhouse facility was non-compliant with certain regulations.  As a result, Health Canada placed a hold on 5,200 kilograms of dried cannabis harvested from the unlicensed rooms and on an additional 7,500 kilograms voluntarily held by the Company.

Most recently, on July 11, 2019, Defendants announced CannTrust (1) suspended sales and shipments of all of its cannabis products and (2) established a special committee to investigate the matter in its entirety.

“We’re focused on investors’ losses and whether Defendants misrepresented and concealed CannTrust’s compliance with applicable laws and regulations,” said Hagens Berman partner Reed Kathrein.

Whistleblowers:   Persons with non-public information regarding CannTrust should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email CTST@hbsslaw.com .

About Hagens Berman Hagens Berman is a nationwide law firm that represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes is located at hbsslaw.com .  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw .

Contact: Reed Kathrein, 510-725-3000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 182

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 120

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 131

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 377

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 271

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 32

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
AI Shopping Surge: WeFetch.ai's Bold Rebrand Move

Updated Category News Views 15

Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 464

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Updated Category News Views 13

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 57

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading

Top 5 Most Recently Viewed Articles

Targa Resources Engages in Key Energy Conference Activities

Updated Category News Views 169

Targa Resources Corp. Engages in Key Energy Conference Activities HOUSTON — Targa Resources Corp. (NYSE: TRGP) has announced its participation in the upcoming BofA Securities Global Energy Conference. This lively event provides a platform for engaging with investors and showcasing the company’s strategic vision in the midstream sector. Details About the Conference...

Continue Reading
Examining Bit Digital Trends: The Rise in Options Activity

Updated Category News Views 161

Understanding Recent Options Activity of Bit Digital Financial institutions are taking noticeable bearish stances on Bit Digital. A thorough examination of the options history for Bit Digital (NASDAQ: BTBT) reveals a total of 25 unusual trades, warranting a closer look into their implications. Trends in Trader Sentiment Upon delving into trader behaviors, our analysis...

Continue Reading
Innovative Solutions for Future-Ready Secure Endpoint Computing

Updated Category News Views 684

Overview of IGEL's 2025 Innovations In a pivotal showcase at its flagship event, IGEL unveiled more than 20 innovative advancements aimed at transforming secure endpoint computing. These innovations reflect IGEL's commitment to providing enhanced security, compliance, and flexibility at a time when organizations face increasing cyber threats and operational complexities....

Continue Reading
Andelyn Biosciences Enhances Gene Therapy Platform Options

Updated Category News Views 108

Andelyn Biosciences Expands Gene Therapy Offerings Andelyn Biosciences, Inc., a prominent player in the cell and gene therapy sector, has made a significant enhancement to its AAV Curator™ Platform. This development comes through a licensing agreement with the Broad Institute of MIT and Harvard, incorporating the highly anticipated Stanton Lab CNS (Central Nervous...

Continue Reading
Next Chapter for Berkshire Hathaway: Insights from Q2 13F Filing

Updated Category News Views 219

Berkshire Hathaway's Q2 13F Filing Insights Warren Buffett and Berkshire Hathaway Inc (NYSE: BRK) are facing a crucial period as they approach an important 13F filing that could unveil their investment strategy for the near future. This filing is pivotal as it will provide insights into which positions the company has increased or decreased, shedding light on the overall...

Continue Reading